Document Detail


Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia.
MedLine Citation:
PMID:  23337048     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract The risks of developing diabetes and dyslipidemia among adolescents with schizophrenia and bipolar disorder have not been well-characterized. This study was designed to characterize these risks and compare them among adolescents in the general population. Methods: This retrospective cohort study used claims data from a large U.S. health insurer to identify adolescents (13-17 years) with claims for schizophrenia or bipolar disorder from 1997 to 2006. Adolescents without evidence of schizophrenia or bipolar disorder were randomly selected for comparison. Study outcomes were new diagnoses of diabetes and dyslipidemia. Results: We identified 17,884 adolescents with schizophrenia or bipolar disorder and 188,059 for the general population cohort. The incidence rate per 100,000 person-years of diabetes was higher in the schizophrenia or bipolar disorder cohort [424.3 (95% CI: 344.5-517.3)] than in the general population cohort (90.0 [95% CI: 79.6-101.3]). The incidence rate per 100,000 person-years of dyslipidemia was 346.4 (95% CI: 274.9-431.0) in the schizophrenia or bipolar disorder cohort and 86.6 (95% CI: 76.4-97.7) in the general population cohort. The adjusted hazard ratios of developing diabetes and dyslipidemia in the schizophrenia or bipolar disorder cohort relative to the general population cohort were 1.76 (95% CI: 1.15-2.72) and 1.66 (95% CI: 1.22-2.28), respectively. Adolescents with schizophrenia or bipolar disorder treated with antipsychotics had a higher risk of developing diabetes and dyslipidemia than those who were untreated. Conclusions: Adolescents with schizophrenia or bipolar disorder had significantly increased risks of developing diabetes and dyslipidemia compared to adolescents without these disorders.
Authors:
Cheryl Enger; Meghan E Jones; Ludmila Kryzhanovskaya; Michael Doherty; Andrew T Mc Afee
Related Documents :
23848988 - Comorbidity of migraine and psychiatric disorders among substance-dependent inpatients.
23756178 - Meta-analysis confirms a functional polymorphism (5-httlpr) in the serotonin transporte...
14593178 - Origin and migration of the alpine iceman.
24964928 - Common etiological factors of attention-deficit/hyperactivity disorder and suicidal beh...
22649348 - Macular hypoplasia in congenital disorder of glycosylation type ia.
11390298 - Decision making and neuropsychiatry.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  International journal of adolescent medicine and health     Volume:  -     ISSN:  0334-0139     ISO Abbreviation:  Int J Adolesc Med Health     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8506960     Medline TA:  Int J Adolesc Med Health     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-9     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Personal and family attributes of pregnant teenagers: findings from a community-based study in Sri L...
Next Document:  Weight gain in an eating disorders day program.